Cytiva Europe GmbH
Technologies and services that are shaping a new age of healthcare
Advancing the development and manufacture of therapeutics
Improving access to life-changing therapies that transform human health
Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. We have a rich heritage tracing back hundreds of years, and a fresh beginning since 2020.
Our customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Our job is to supply the tools and services they need to work better, faster and safer, leading to better patient outcomes.
Cytiva is a 3.3 billion USD global life sciences leader with over 7000 associates across 40 sites who are dedicated to our vision to improve access to life-changing therapies that transform human health. As a trusted partner to customers that range in scale and scope, Cytiva brings efficiencies to research and manufacturing workflows, ensuring the development, manufacture and delivery of transformative medicines to patients.
- Founding: 2020
- Focus : Manufacturer
- Employees: 5,001-10,000
- Industry : Biotechnology
Cytiva Products in the Spotlight
Whatman QM-C quartz filter paper
High purity and high temperature resistance quartz filter paper for air particulate testing
Anopore inorganic membranes
The aluminum oxide filter membrane that can increase the purity or yield of your analyte
Easy Documentation of Gels & Blots: New Generation of Highly Sensitive & Robust CCD Imaging Devices
The Ideal Solution for Chemiluminescence, Fluorescence and Colorimetric Imaging
New Generation SEC Columns for Small-Scale Preparative Purification and Analysis of Proteins
Maximized Resolution and Optimized Run Time for Small-Scale Preparative Purification and Analysis
Products from Cytiva
News about Cytiva
03-Aug-2021 | Finances
Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions
An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher Corporation, will expand manufacturing capacity and services across ...
02-Jul-2021 | Business
Cytiva acquires Intermountain Life Sciences
Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain ...
01-Apr-2020 | Business
Cytiva, a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics, launches. ...
21-Jan-2020 | Manufacturing
GE Healthcare Life Sciences plans new manufacturing facility in Switzerland
GE Healthcare Life Sciences is building a new 7,360 square meter facility in Grens, Switzerland, in the new Signy Park, for the manufacture of single use ...